UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016922
Receipt number R000019641
Scientific Title Research on the effectiveness and safety of breast imaging diagnostic equipment (Microwave scattering field tomography imaging system)
Date of disclosure of the study information 2015/03/27
Last modified on 2020/09/15 13:43:12

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on the effectiveness and safety of microwave mammography

Acronym

Research on the effectiveness and safety of microwave mammography

Scientific Title

Research on the effectiveness and safety of breast imaging diagnostic equipment (Microwave scattering field tomography imaging system)

Scientific Title:Acronym

Research on the effectiveness and safety of breast imaging diagnostic equipment (Microwave scattering field tomography imaging system)

Region

Japan


Condition

Condition

breast cancer

Classification by specialty

Breast surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

In this study, we will confirm the ability to visualize the intramammary structure on microwave mammography images and clarify its usefulness in diagnosis. In addition, we will investigate the effects of weak microwaves on living organisms and evaluate their safety.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Drawability (Efficacy) of microwave mammography image by microwave mammography device.

Key secondary outcomes

1. We evaluate the safety from the viewpoint of the
thermal action of the breast imaging diagnostic apparatus.
2. We evaluate the safety and usefulness of the protective seal.
3. Compared with X-ray mammography images, ultrasonic examination images, MRI examination images, etc., we evaluate the imaging ability of microwave mammography.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Prevention

Type of intervention

Device,equipment

Interventions/Control_1

Electromagnetic wave from breast cancer of person is measured by irradiating extremely weak electromagnetic wave below an environmental one. The strength of adopted electromagnetic wave is one digit smaller than one of wireless LAN device, and testing time required is within 30 minutes.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

16 years-old <=

Age-upper limit


Not applicable

Gender

Female

Key inclusion criteria

Selection criteria for cancer patients
1) Breast cancer is suspected by imaging diagnosis or diagnosed as breast cancer by pathological diagnosis.
2) Regardless of sex, over 16 years old.
3) It is possible to maintain the supine state on the bed during the examination of about 20 minutes.
4) Regarding research participation, written informed consent was obtained from the subject himself. In the case of an underage, written informed consent has been obtained from parents. Selection criteria for

healthy person
1) Breast cancer is not suspected by diagnostic imaging .
2) Regardless of sex, over 16 years old.
3) It is possible to maintain the supine state on the bed during the examination of about 20 minutes.
4) Regarding research participation, written informed consent was obtained from the subject himself. In the case of an underage, written informed consent has been obtained from parents.

Key exclusion criteria

1) There is a trauma that is not cured on the breast surface.
2) In addition, the subject who judged it though a study responsibility doctor or the medical attendant carried out this study safely if inadequate.

Target sample size

300


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Kenjiro Kimura

Organization

Kobe University

Division name

Graduate School of Science

Zip code


Address

1-1 Rokkodai-cho, Nada-ku, Kobe 657-8501

TEL

078-803-5702

Email

kimura@gold.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Kenjiro Kimura

Organization

Kobe University

Division name

Graduate School of Science

Zip code


Address

1-1 Rokkodai-cho, Nada-ku, Kobe 657-8501

TEL

078-803-5702

Homepage URL


Email

kimura@gold.kobe-u.ac.jp


Sponsor or person

Institute

Graduate School of Science, Kobe University
Kenjiro Kimura research group

Institute

Department

Personal name



Funding Source

Organization

Ministry of Public Management, Home Affairs,
Posts and Telecommunications

Organization

Division

Category of Funding Organization

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 03 Month 27 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2014 Year 09 Month 01 Day

Date of IRB


Anticipated trial start date

2015 Year 04 Month 06 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 03 Month 26 Day

Last modified on

2020 Year 09 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000019641


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name